89 related articles for article (PubMed ID: 14628087)
1. Low antigen-dependent activity of T cells after repeated stimulation using dendritic cells and expansion with interleukin-2.
Büchler T; Hájek R; Kovárova L; Musilová R; Bourková L; Cech Z; Vánová P; Tůzová E; Vidláková P; Vorlícek J; Penka M
Neoplasma; 2003; 50(5):345-9. PubMed ID: 14628087
[TBL] [Abstract][Full Text] [Related]
2. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells.
Galetto A; Contarini M; Sapino A; Cassoni P; Consalvo E; Forno S; Pezzi C; Barnaba V; Mussa A; Matera L
J Surg Res; 2001 Sep; 100(1):32-8. PubMed ID: 11516202
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
6. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
7. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
Zhou CJ; Ma W; Zhou JD; Zhao YX; Xie HQ
Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
Eksioglu EA; Mahmood SS; Chang M; Reddy V
Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
[TBL] [Abstract][Full Text] [Related]
9. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro].
Xing LH; Wang FS; Zhu CL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):365-8. PubMed ID: 15340554
[TBL] [Abstract][Full Text] [Related]
11. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
[TBL] [Abstract][Full Text] [Related]
12. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J; Jacobs P; Doffek K; Sugg SL
J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
[TBL] [Abstract][Full Text] [Related]
13. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
16. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
[TBL] [Abstract][Full Text] [Related]
17. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
[TBL] [Abstract][Full Text] [Related]
18. IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells.
Ahn JS; Agrawal B
Int Immunol; 2005 Oct; 17(10):1337-46. PubMed ID: 16141241
[TBL] [Abstract][Full Text] [Related]
19. Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
Renneson J; Salio M; Mazouz N; Goldman M; Marchant A; Cerundolo V
Clin Exp Immunol; 2005 Mar; 139(3):468-75. PubMed ID: 15730392
[TBL] [Abstract][Full Text] [Related]
20. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]